+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Osteobiologics Market - Global Forecast 2026-2032- Product Image
Osteobiologics Market - Global Forecast 2026-2032- Product Image
Sale

Osteobiologics Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968632
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Osteobiologics Market is projected to reach USD 9.42 Billion in 2026. It is expected to continue growing at a CAGR of 5.79%, reaching USD 13.22 Billion by 2032.

The osteobiologics market is advancing as orthopedic, spine, trauma, dental, and craniomaxillofacial surgeons seek bone graft substitutes that support bone healing, improve fusion, fill skeletal defects, and reduce dependence on autograft harvesting. Core product families include allografts, demineralized bone matrix, synthetic ceramics, bioactive glass, bone morphogenetic protein products, cell-based matrices, and platelet-derived biologic solutions.

Demand is supported by measurable demographic and clinical fundamentals. The World Health Organization reports that the global population aged 60 years and older is projected to reach 1.4 billion by 2030 and 2.1 billion by 2050, increasing the burden of osteoporosis, degenerative disc disease, fragility fractures, delayed unions, and revision procedures. These trends position osteobiologics as a critical segment of regenerative orthopedic medicine and bone regeneration technologies.

Transformative Shifts in the Osteobiologics Landscape

The osteobiologics landscape is shifting from traditional autograft-centric care toward off-the-shelf, procedure-specific biologic solutions. Hospitals and surgeons increasingly evaluate osteobiologics on fusion performance, handling characteristics, sterility assurance, safety profile, reimbursement fit, and total episode-of-care value rather than product innovation alone.

Transformative forces include stricter regulatory evidence expectations, wider use of minimally invasive spine surgery, additive manufacturing of porous scaffolds, and broader adoption of synthetic bone graft substitutes. EU Medical Device Regulation, FDA oversight of biologic-device combination products, tissue-bank standards, and hospital value analysis committees are reshaping product development, labeling, sourcing, and commercialization strategies across orthopedic biologics.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating practical value across osteobiologics by improving patient stratification, procedure planning, imaging interpretation, implant-fit assessment, and prediction of nonunion or fusion failure risk. AI-enabled analytics can help surgeons identify patients who may benefit from enhanced biologic support, particularly in complex spine fusion, trauma reconstruction, and revision orthopedic procedures.

Beyond clinical decision support, AI accelerates materials discovery, scaffold design, manufacturing quality control, adverse-event monitoring, and supply forecasting for biologic and synthetic graft portfolios. Adoption must remain evidence-led, with validated datasets, cybersecurity safeguards, bias management, and clear accountability under evolving FDA, EMA, and institutional AI governance frameworks.

Key Regional Insights

Asia-Pacific is gaining momentum as China, India, Japan, South Korea, and Australia invest in orthopedic capacity, private hospital infrastructure, and local medtech manufacturing. Aging populations in Japan and South Korea, large trauma and degenerative disease pools in China and India, and improving access to advanced spine surgery support durable osteobiologics demand. The region is also influenced by medical tourism, expanding specialist training, and increasing use of synthetic bone graft substitutes where cost, availability, and consistency are key purchasing factors.

North America remains the most mature adoption environment due to high surgical volumes, established orthopedic and spine networks, advanced reimbursement pathways, and rapid uptake of premium spine biologics in the United States and Canada. Europe is shaped by MDR compliance, evidence generation, national procurement controls, and strong clinical governance, while Latin America relies heavily on Brazil and Mexico for advanced orthopedic access. The Middle East, led by GCC hospital investment and specialty care expansion, is moving toward advanced spine and trauma centers, whereas Africa shows longer-term potential tied to trauma care, urban hospital expansion, workforce development, and improved access to surgical infrastructure.

Key Group Insights

ASEAN markets benefit from medical tourism, expanding private hospitals, and growing orthopedic procedure volumes in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines. The GCC is driven by government-backed hospital modernization, specialist surgery centers, and demand for advanced spine, trauma, and dental bone regeneration procedures. Across both groups, adoption depends on surgeon training, regulatory registration timelines, distributor capability, and the ability to demonstrate clinical reliability in cost-sensitive procurement environments.

The European Union is defined by harmonized but more demanding regulatory compliance under MDR, which favors products supported by strong clinical evidence, traceable sourcing, and post-market surveillance. BRICS markets offer scale, localization incentives, and rising surgical access across China, India, Brazil, Russia, and South Africa, while G7 countries remain leading adopters of high-value osteobiologics due to mature hospital infrastructure and evidence-based purchasing. NATO member markets collectively emphasize supply resilience, quality assurance, procurement transparency, and alignment with advanced regulatory and healthcare security standards.

Key Country Insights

The United States leads adoption through large spine, trauma, sports medicine, dental, and reconstructive procedure volumes, while Canada emphasizes evidence-based purchasing, public reimbursement discipline, and provincial health technology assessment. Mexico and Brazil are important Latin American anchors, supported by private hospital networks, orthopedic training centers, and expanding access to complex spine and trauma surgery.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine aging populations with strong orthopedic infrastructure, clinical registries, and demand for validated bone graft substitutes, while Russia remains influenced by localization priorities and procurement constraints. China and India provide large long-term procedural opportunity through expanding surgical access and hospital investment. Japan and South Korea lead in advanced clinical adoption supported by aging demographics, sophisticated spine practices, and high standards for product quality, while Australia combines strong public-private healthcare delivery with uptake of evidence-backed osteobiologics in orthopedic, dental, and trauma applications.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically differentiated osteobiologics portfolios that match specific procedures, including spinal fusion, fracture repair, dental bone regeneration, and revision arthroplasty. Evidence generation should include comparative outcomes, real-world registry data, complication tracking, biologic safety monitoring, and health-economic models that demonstrate value to surgeons, payers, and hospital procurement teams.

Companies should strengthen supply-chain resilience, tissue sourcing transparency, surgeon education, and regulatory readiness across FDA, EU MDR, and local market requirements. Partnerships with hospitals, academic centers, and AI analytics providers can accelerate product validation, while regional manufacturing or distribution alliances can improve access in high-growth Asia-Pacific, GCC, ASEAN, and BRICS markets.

Research Methodology

This executive summary is built on a structured research methodology that triangulates secondary research, primary industry validation, regulatory review, public clinical literature, hospital procurement trends, reimbursement references, and public datasets from organizations such as WHO, OECD, FDA, EMA, and national health authorities.

The analysis evaluates demand drivers, product innovation, procedure adoption, regional health-system capacity, regulatory dynamics, reimbursement patterns, tissue safety standards, and competitive positioning without relying on market sizing, market share, or forecasting. Findings are validated through cross-source consistency checks and market-factor mapping to ensure insights remain data-backed, commercially relevant, and suitable for strategic decision-making in the osteobiologics industry.

Conclusion

Osteobiologics are becoming essential to modern orthopedic and spine care as providers manage aging populations, fracture burden, degenerative disease, dental reconstruction needs, and demand for less invasive, higher-value surgery. Momentum is strongest where clinical evidence, reimbursement access, surgeon confidence, regulatory readiness, and reliable supply converge.

Future leadership will depend on procedure-specific innovation, disciplined regulatory execution, AI-enabled decision support, and demonstrable patient outcomes. Organizations that combine validated bone regeneration technologies with regional access strategies, transparent sourcing, and value evidence will be best positioned to build sustainable relevance in the global osteobiologics landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Osteobiologics Market, by Product Type
7.1. Introduction
7.2. Bone Graft Substitutes
7.2.1. Allografts
7.2.1.1. Demineralized Bone Matrix
7.2.1.2. Mineralized Bone Allografts
7.2.1.3. Machined Allografts
7.2.2. Synthetic Bone Grafts
7.2.2.1. Calcium Phosphate
7.2.2.2. Calcium Sulfate
7.2.2.3. Polymer-based Substitutes
7.2.3. Xenografts
7.3. Bone Morphogenetic Proteins
7.3.1. Recombinant BMP-2
7.3.2. Recombinant BMP-7
7.4. Cell-Based Matrices
7.4.1. Mesenchymal Stem Cells
7.4.2. Bone Marrow Aspirate Concentrates
7.4.3. Adipose-Derived Stem Cells
8. Osteobiologics Market, by Formulation Type
8.1. Introduction
8.2. Putty
8.3. Paste
8.4. Granules
8.5. Gel
9. Osteobiologics Market, by Mechanism of Action
9.1. Introduction
9.2. Osteoconductive
9.3. Osteoinductive
9.4. Osteogenic
10. Osteobiologics Market, by Surgical Approach
10.1. Introduction
10.2. Open Surgery
10.3. Minimally Invasive Surgery
11. Osteobiologics Market, by Application
11.1. Introduction
11.2. Spinal Fusion
11.2.1. Cervical Fusion
11.2.2. Thoracolumbar Fusion
11.3. Trauma & Extremities
11.3.1. Fracture Repair
11.3.2. Limb Reconstruction
11.4. Joint Reconstruction
11.4.1. Hip
11.4.2. Knee
11.4.3. Shoulder
11.5. Sports Injuries
11.6. Orthobiologics for Osteoarthritis
11.7. Craniomaxillofacial
11.7.1. Dental Bone Grafting
11.7.2. Facial Reconstruction
12. Osteobiologics Market, by End-User
12.1. Introduction
12.2. Hospitals
12.2.1. Public
12.2.2. Private
12.3. Orthopedic Clinics
12.4. Ambulatory Surgical Centers
12.5. Dental Clinics
12.6. Research & Academic Institutes
13. Osteobiologics Market, by Distribution Channel
13.1. Introduction
13.2. Offline
13.3. Online
14. Osteobiologics Market, by Region
14.1. Asia-Pacific
14.2. Europe
14.3. North America
14.4. Latin America
14.5. Africa
14.6. Middle East
15. Osteobiologics Market, by Group
15.1. NATO
15.2. G7
15.3. European Union
15.4. BRICS
15.5. ASEAN
15.6. GCC
16. Osteobiologics Market, by Country
16.1. United States
16.2. China
16.3. Germany
16.4. Japan
16.5. India
16.6. United Kingdom
16.7. France
16.8. Canada
16.9. Italy
16.10. Australia
16.11. South Korea
16.12. Brazil
16.13. Mexico
16.14. Russia
16.15. Spain
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. AlloSource
18.2. Arthrex Inc
18.3. Baxter International Inc
18.4. Bioventus Inc
18.5. Bone Biologics Corporation
18.6. BoneSupport AB
18.7. Cerapedics Inc
18.8. DePuy Synthes
18.9. Exactech Inc
18.10. Geistlich Pharma AG
18.11. Globus Medical Inc
18.12. Integra LifeSciences Holdings Corporation
18.13. Isto Biologics
18.14. Kuros Biosciences AG
18.15. LifeNet Health, Inc.
18.16. Medtronic plc
18.17. NuVasive Inc
18.18. Orthofix Medical Inc
18.19. OssDsign AB
18.20. Ossio Ltd
18.21. Regenity Biosciences
18.22. SeaSpine Holdings Corporation
18.23. Smith & Nephew plc
18.24. Stryker Corporation
18.25. Xtant Medical Holdings Inc
18.26. Zimmer Biomet Holdings Inc
List of Figures
FIGURE 1. GLOBAL OSTEOBIOLOGICS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL OSTEOBIOLOGICS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL OSTEOBIOLOGICS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL OSTEOBIOLOGICS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL OSTEOBIOLOGICS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2025 VS 2032 (%)
FIGURE 13. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
FIGURE 17. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL OSTEOBIOLOGICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL OSTEOBIOLOGICS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL OSTEOBIOLOGICS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL OSTEOBIOLOGICS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL BONE GRAFT SUBSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL BONE GRAFT SUBSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL BONE GRAFT SUBSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ALLOGRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ALLOGRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL DEMINERALIZED BONE MATRIX MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL MINERALIZED BONE ALLOGRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL MINERALIZED BONE ALLOGRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL MINERALIZED BONE ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL MACHINED ALLOGRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL MACHINED ALLOGRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL MACHINED ALLOGRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL SYNTHETIC BONE GRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL SYNTHETIC BONE GRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL SYNTHETIC BONE GRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL CALCIUM PHOSPHATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL CALCIUM SULFATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CALCIUM SULFATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CALCIUM SULFATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL POLYMER-BASED SUBSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL POLYMER-BASED SUBSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL POLYMER-BASED SUBSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL XENOGRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL XENOGRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL XENOGRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL BONE MORPHOGENETIC PROTEINS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL BONE MORPHOGENETIC PROTEINS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL BONE MORPHOGENETIC PROTEINS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL RECOMBINANT BMP-2 MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL RECOMBINANT BMP-2 MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL RECOMBINANT BMP-2 MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL RECOMBINANT BMP-7 MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL RECOMBINANT BMP-7 MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL RECOMBINANT BMP-7 MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CELL-BASED MATRICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CELL-BASED MATRICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CELL-BASED MATRICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL MESENCHYMAL STEM CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL BONE MARROW ASPIRATE CONCENTRATES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL BONE MARROW ASPIRATE CONCENTRATES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL BONE MARROW ASPIRATE CONCENTRATES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ADIPOSE-DERIVED STEM CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ADIPOSE-DERIVED STEM CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL ADIPOSE-DERIVED STEM CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL PUTTY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL PUTTY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL PUTTY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PASTE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL PASTE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL PASTE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL GRANULES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL GRANULES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL GRANULES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL GEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL GEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL GEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL OSTEOCONDUCTIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL OSTEOCONDUCTIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL OSTEOCONDUCTIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL OSTEOINDUCTIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL OSTEOINDUCTIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL OSTEOINDUCTIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL OSTEOGENIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL OSTEOGENIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL OSTEOGENIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL OPEN SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL OPEN SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL OPEN SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL SPINAL FUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL SPINAL FUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL SPINAL FUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL CERVICAL FUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL CERVICAL FUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL CERVICAL FUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL THORACOLUMBAR FUSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL THORACOLUMBAR FUSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL THORACOLUMBAR FUSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL TRAUMA & EXTREMITIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL TRAUMA & EXTREMITIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL TRAUMA & EXTREMITIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL FRACTURE REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL FRACTURE REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL FRACTURE REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL LIMB RECONSTRUCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL LIMB RECONSTRUCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL LIMB RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL JOINT RECONSTRUCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL JOINT RECONSTRUCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL JOINT RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL HIP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL HIP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL HIP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL KNEE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL KNEE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL KNEE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL SHOULDER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL SHOULDER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL SHOULDER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL SPORTS INJURIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL SPORTS INJURIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL SPORTS INJURIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL ORTHOBIOLOGICS FOR OSTEOARTHRITIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL ORTHOBIOLOGICS FOR OSTEOARTHRITIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL ORTHOBIOLOGICS FOR OSTEOARTHRITIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL CRANIOMAXILLOFACIAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL CRANIOMAXILLOFACIAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL CRANIOMAXILLOFACIAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL DENTAL BONE GRAFTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL DENTAL BONE GRAFTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL DENTAL BONE GRAFTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL FACIAL RECONSTRUCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL FACIAL RECONSTRUCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL FACIAL RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL PUBLIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL PUBLIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL PUBLIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL PRIVATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL PRIVATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL PRIVATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL ORTHOPEDIC CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL ORTHOPEDIC CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL ORTHOPEDIC CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL DENTAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL DENTAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL DENTAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL RESEARCH & ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2017-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2017-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2017-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2017-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2017-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2017-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2017-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 179. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 180. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 181. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 182. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2017-2032 (USD MILLION)
TABLE 183. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2017-2032 (USD MILLION)
TABLE 184. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2017-2032 (USD MILLION)
TABLE 185. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2017-2032 (USD MILLION)
TABLE 186. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 187. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 188. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 189. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 190. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 191. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2017-2032 (USD MILLION)
TABLE 192. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2017-2032 (USD MILLION)
TABLE 193. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2017-2032 (USD MILLION)
TABLE 194. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 195. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 196. EUROPE OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 197. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 198. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 199. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 200. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2017-2032 (USD MILLION)
TABLE 201. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2017-2032 (USD MILLION)
TABLE 202. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2017-2032 (USD MILLION)
TABLE 203. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2017-2032 (USD MILLION)
TABLE 204. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 205. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 206. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 207. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 208. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 209. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2017-2032 (USD MILLION)
TABLE 210. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2017-2032 (USD MILLION)
TABLE 211. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2017-2032 (USD MILLION)
TABLE 212. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 213. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 214. NORTH AMERICA OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 215. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 216. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 217. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 218. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2017-2032 (USD MILLION)
TABLE 219. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2017-2032 (USD MILLION)
TABLE 220. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2017-2032 (USD MILLION)
TABLE 221. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2017-2032 (USD MILLION)
TABLE 222. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 223. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 224. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 225. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 226. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 227. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2017-2032 (USD MILLION)
TABLE 228. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2017-2032 (USD MILLION)
TABLE 229. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2017-2032 (USD MILLION)
TABLE 230. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 231. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 232. LATIN AMERICA OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 233. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 234. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 235. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 236. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2017-2032 (USD MILLION)
TABLE 237. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2017-2032 (USD MILLION)
TABLE 238. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2017-2032 (USD MILLION)
TABLE 239. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2017-2032 (USD MILLION)
TABLE 240. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 241. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 242. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 243. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 244. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 245. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2017-2032 (USD MILLION)
TABLE 246. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2017-2032 (USD MILLION)
TABLE 247. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2017-2032 (USD MILLION)
TABLE 248. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 249. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 250. AFRICA OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 251. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 252. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 253. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 254. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2017-2032 (USD MILLION)
TABLE 255. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2017-2032 (USD MILLION)
TABLE 256. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2017-2032 (USD MILLION)
TABLE 257. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2017-2032 (USD MILLION)
TABLE 258. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 259. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 260. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 261. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 262. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 263. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2017-2032 (USD MILLION)
TABLE 264. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2017-2032 (USD MILLION)
TABLE 265. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2017-2032 (USD MILLION)
TABLE 266. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 267. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 268. MIDDLE EAST OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 269. GLOBAL OSTEOBIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 270. NATO OSTEOBIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 271. NATO OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 272. NATO OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 273. NATO OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2017-2032 (USD MILLION)
TABLE 274. NATO OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2017-2032 (USD MILLION)
TABLE 275. NATO OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2017-2032 (USD MILLION)
TABLE 276. NATO OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2017-2032 (USD MILLION)
TABLE 277. NATO OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 278. NATO OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 279. NATO OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 280. NATO OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 281. NATO OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 282. NATO OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2017-2032 (USD MILLION)
TABLE 283. NATO OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2017-2032 (USD MILLION)
TABLE 284. NATO OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2017-2032 (USD MILLION)
TABLE 285. NATO OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 286. NATO OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 287. NATO OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 288. G7 OSTEOBIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 289. G7 OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 290. G7 OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 291. G7 OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2017-2032 (USD MILLION)
TABLE 292. G7 OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2017-2032 (USD MILLION)
TABLE 293. G7 OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2017-2032 (USD MILLION)
TABLE 294. G7 OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2017-2032 (USD MILLION)
TABLE 295. G7 OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 296. G7 OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 297. G7 OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 298. G7 OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 299. G7 OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 300. G7 OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2017-2032 (USD MILLION)
TABLE 301. G7 OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2017-2032 (USD MILLION)
TABLE 302. G7 OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2017-2032 (USD MILLION)
TABLE 303. G7 OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 304. G7 OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 305. G7 OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 306. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 307. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 308. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 309. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2017-2032 (USD MILLION)
TABLE 310. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2017-2032 (USD MILLION)
TABLE 311. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2017-2032 (USD MILLION)
TABLE 312. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2017-2032 (USD MILLION)
TABLE 313. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 314. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 315. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 316. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 317. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 318. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2017-2032 (USD MILLION)
TABLE 319. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2017-2032 (USD MILLION)
TABLE 320. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2017-2032 (USD MILLION)
TABLE 321. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 322. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 323. EUROPEAN UNION OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 324. BRICS OSTEOBIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 325. BRICS OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 326. BRICS OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 327. BRICS OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2017-2032 (USD MILLION)
TABLE 328. BRICS OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2017-2032 (USD MILLION)
TABLE 329. BRICS OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2017-2032 (USD MILLION)
TABLE 330. BRICS OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2017-2032 (USD MILLION)
TABLE 331. BRICS OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 332. BRICS OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 333. BRICS OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 334. BRICS OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 335. BRICS OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 336. BRICS OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2017-2032 (USD MILLION)
TABLE 337. BRICS OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2017-2032 (USD MILLION)
TABLE 338. BRICS OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2017-2032 (USD MILLION)
TABLE 339. BRICS OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 340. BRICS OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 341. BRICS OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 342. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 343. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 344. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 345. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2017-2032 (USD MILLION)
TABLE 346. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2017-2032 (USD MILLION)
TABLE 347. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2017-2032 (USD MILLION)
TABLE 348. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2017-2032 (USD MILLION)
TABLE 349. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 350. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 351. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 352. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 353. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY SPINAL FUSION, 2017-2032 (USD MILLION)
TABLE 354. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY TRAUMA & EXTREMITIES, 2017-2032 (USD MILLION)
TABLE 355. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY JOINT RECONSTRUCTION, 2017-2032 (USD MILLION)
TABLE 356. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY CRANIOMAXILLOFACIAL, 2017-2032 (USD MILLION)
TABLE 357. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 358. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 359. ASEAN OSTEOBIOLOGICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 360. GCC OSTEOBIOLOGICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 361. GCC OSTEOBIOLOGICS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 362. GCC OSTEOBIOLOGICS MARKET SIZE, BY BONE GRAFT SUBSTITUTES, 2017-2032 (USD MILLION)
TABLE 363. GCC OSTEOBIOLOGICS MARKET SIZE, BY ALLOGRAFTS, 2017-2032 (USD MILLION)
TABLE 364. GCC OSTEOBIOLOGICS MARKET SIZE, BY SYNTHETIC BONE GRAFTS, 2017-2032 (USD MILLION)
TABLE 365. GCC OSTEOBIOLOGICS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, 2017-2032 (USD MILLION)
TABLE 366. GCC OSTEOBIOLOGICS MARKET SIZE, BY CELL-BASED MATRICES, 2017-2032 (USD MILLION)
TABLE 367. GCC OSTEOBIOLOGICS MARKET SIZE, BY FORMULATION TYPE, 2017-2032 (USD MILLION)
TABLE 368. GCC OSTEOBIOLOGICS MARKET SIZE, BY MECHANISM OF ACTION, 2017-2032 (USD MILLION)
TABLE 369. GCC OSTEOBIOLOGICS MARKET SIZE, BY SURGICAL APPROACH, 2017-2032 (USD MILLION)
TABLE 370. GCC OSTEOBIOLOGICS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION

Companies Mentioned

  • AlloSource
  • Arthrex Inc
  • Baxter International Inc
  • Bioventus Inc
  • Bone Biologics Corporation
  • BoneSupport AB
  • Cerapedics Inc
  • DePuy Synthes
  • Exactech Inc
  • Geistlich Pharma AG
  • Globus Medical Inc
  • Integra LifeSciences Holdings Corporation
  • Isto Biologics
  • Kuros Biosciences AG
  • LifeNet Health, Inc.
  • Medtronic plc
  • NuVasive Inc
  • Orthofix Medical Inc
  • OssDsign AB
  • Ossio Ltd
  • Regenity Biosciences
  • SeaSpine Holdings Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Xtant Medical Holdings Inc
  • Zimmer Biomet Holdings Inc

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 9.42 Billion
Forecasted Market Value ( USD ) by 2032 $ 13.22 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Osteobiologics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Osteobiologics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 192 Pages
  • Global
From
Spinal Stenosis Implant Market Size, Share & Growth Analysis Report - Industry Trends, Competitive Landscape, Segment Insights and Forecast 2024-2034 - Product Image

Spinal Stenosis Implant Market Size, Share & Growth Analysis Report - Industry Trends, Competitive Landscape, Segment Insights and Forecast 2024-2034

  • Report
  • 160 Pages
  • Global
From
Bone Morphogenetic Protein Market - Global Forecast 2026-2032 - Product Image

Bone Morphogenetic Protein Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Lumbar Degenerative Disc Disease Market - Global Forecast 2026-2032 - Product Image

Lumbar Degenerative Disc Disease Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Bone Morphogenetic Protein Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Bone Morphogenetic Protein Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From

About the Market

The Osteobiologics market is a subset of the biopharmaceuticals industry, focusing on the development of treatments and therapies for bone-related diseases and conditions. Osteobiologics products are typically used to treat bone fractures, osteoporosis, and other bone-related diseases. These products are typically derived from natural sources, such as bone marrow, and are designed to promote bone healing and regeneration. Osteobiologics products are typically used in combination with other treatments, such as physical therapy, to provide a comprehensive approach to bone healing and regeneration. Osteobiologics products are also used to treat bone-related conditions such as osteoarthritis, bone tumors, and bone infections. Some of the companies in the Osteobiologics market include Stryker Corporation, Zimmer Biomet, Medtronic, Smith & Nephew, and Orthofix International. These companies are involved in the development, manufacture, and marketing of Osteobiologics products. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.